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A B S T R A C T
Background: Brucellosis is the most common global zoonosis and an important public health problem in many parts of the world including Iran. Diagnosis of brucellosis is frequently difficult to establish and conventional methods are not always successful in identifying the organisms. Rapid detection of Brucella species by an automated blood culture system and Polymerase Chain Reaction (PCR) may lead to an earlier diagnosis and may improve patient management.
Objectives: The current study aimed to evaluate PCR technique as a diagnostic tool for brucellosis in comparison to conventional bacteriological techniques.
Materials and Methods: A total of 50 patients suspected to have brucellosis were included in this study. All patients presented clinical signs compatible with brucellosis. Diagnosis was established by detecting a titer equal to or greater than 1:160 by the standard tube agglutination (STA) method. Blood samples and sera from the patients were tested by culture using BACTEC 9050 system and PCR using primer set to amplify a 223 bp region with in the gene coding for a 31 KD Brucella antigen.
Results: Eleven (22%) whole blood samples and 17 (34%) serum samples out of 50 had positive PCR and 7 (14%) patients had Brucella species grown in their cultures. Out of 43 blood culture negative samples, 10 (23.3 %) were positive with the serum PCR versus in 4(9.3 %) with whole blood PCR.
Conclusions: The results suggest that the serum PCR assay is rapid and easy to perform and highly sensitive and specific, and it may therefore be considered a useful tool for diagnosis of human brucellosis.
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1. BackgroundBrucellosis is a major cause of zoonosis, and an important public health problem in many parts of the world, mostly in the Middle East. The disease is endemic in our area (1, 2). It is a zoonotic disease in which infection is transmitted to humans from domestic animals through direct contact or mostly through consumption of unpasteurized milk and contaminated dairy products. Five hundred thousand new cases are reported worldwide each year, but accord-ing to the World Health Organization, these figures nota-bly underestimate the accurate occurrence of human dis-ease (3). Since the clinical symptoms of human brucellosis are protean and nonspecific, laboratory confirmation by isolation of organism or detection of specific antibodies is necessary for the diagnosis.Blood cultures stand for the “gold standard” of labora-tory diagnosis. However, positive blood cultures occur in 10%- 70% of suspected infections (4), depending on the du-ration, localization of the infection and the type of Brucel-la species. In addition, culturing is time-consuming. Au-tomated blood culture systems may detect Brucella in less than seven days of incubation (5). However, the technol-ogy indeed is not available in most developing countries where the disease is prevalent. In addition, due to their comparatively long doubling time, Brucella species grow slowly on primary cultures and subcultures, while their inert biochemical profiles hamper fast identification of isolates(6). Diverset clinical pictures of the disease such as focal, relapsing, or chronic disease are characterized by low blood culture yields and pose special diagnostic problems (7, 8). Accordingly, detection of Brucella spp. in clinical specimens by cultures may still be difficult and take a long time.Serological tests are more practical than culture tech-niques, while their specificities are low, especially in en-demic areas or in people exposed to Brucella because of their profession. False-positive serological tests may also be caused by other illnesses such as tularemia, cholera, yersiniosis and salmonellosis, (4) while false-negative re-sults may occur early in the course of the disease (9). As for other fastidious pathogens, molecular methodology offers an alternative way to diagnose brucellosis. Nucleic acid amplification techniques, like PCR, characterized by high sensitivity and specificity and short turnaround time can overcome the limitations of conventional meth-odology. Various blood samples including serum, whole blood, and buffy-coat have been used for molecular diag-nosis of brucellosis (10, 11). Further investigation is need-ed to find the best specimen.
2. ObjectivesThe current study aimed to develop a diagnostic PCR as-say and define the optimal clinical specimen for this test. For this purpose, peripheral blood samples, i.e., whole-
blood and serum, from confirmed brucellosis cases were examined.
3. Materials and Methods
3.1. Clinical SpecimensDuring a 15- month period, 50 patients with brucellosis admitted in infectious disease section at Sina Hospital, Hamedan, Iran were included. All patients presented clinical symptoms compatible with those of brucellosis. Diagnosis was established by an anti-Brucella antibody titer equal to or more than 1:160 by the standard tube ag-glutination (STA) method. After obtaining informed con-sent, peripheral blood specimens were collected from pa-tients. The study was approved by the Ethics Committee of Hamedan University of Medical Sciences.
3.2. Microbiological Methods 
Blood cultures were processed with BACTEC 9050 (Bec-ton Dickinson, USA), and between five to seven ml. of blood from patients was inoculated in each of standard aerobic BACTEC bottle and incubated for seven days and subcultured whenever positive signal occurred by instru-ment. Suspected colonies were identified by colonial morphology, Gram-staining and standard biochemical (oxidase, catalase, production of H2S and urease) and ag-glutination test using specious specific antisera. At the end of the first week, bottles with negative growth index were kept for an additional three weeks and blind subcul-tures on Brucella base blood agar (Merck, German) were performed weekly. Cultures were considered negative for Brucella in the face of no growth after four weeks of incu-bation.
3.3. Sample Processing for PCR Isolation of DNA from peripheral blood samples, in-cluded whole blood and serum carried out by commer-cial DNA extraction kit (BIONEER Co, Korea). The primers B4 (5’-TGGCTCGGTTGCCAATATCAA-3’) and B5 (5’- CGCGCTT-GCCTTTCAGGTCTG-3’), described previously by Bailey et al. (12), were used to amplify a target sequence of 223-bp within a gene code  to produce a 31-kDa outer membrane protein specific to B. abortus, which is conserved in all Bru-cella species (13). PCR was performed using a 25 μL volume reaction mixture containing 10 mM tris-HCl (pH 8.4), 50 
mM KCl, 1.5 mM MgCl2, 200 μM each deoxyribonucleotide triphosphate (dATP, dGTP, dTTP, dCTP, Fermentas Co), 0.5 U of Taq polymerase (Fermentas Co), oligonucleotide B4 
and B5 (10 pM each) and μG of total DNA extracted was processed in a thermocycler (Eppendorf Co).The cycling conditions consisted of initial denaturation at 95 C for five minutes, followed by 35 cycles of 60 sec-onds of template denaturation at 95°C, 30s of primer an-
Diagnosis of Brucellosis by PCRAlikhani MY et al.
Jundishapur J Microbiol. 2013;6(3)250
nealing at 60°C, and 1 min. of primer extension at 72°C and final extension at 72°C for seven minutes. Negative controls containing all of the reagents but lacking tem-plate DNA were routinely processed exactly as described above to monitor contamination with Brucella DNA and were negative in all experiments. Positive controls with genomic DNA isolated from a suspension of B. abortus B-19 were also included in each experiment. All PCRs were 
carried out in duplicate. The products (15 μl from each re-action mixture) were analyzed by agarose gel (1.5%) elec-trophoresis at 80v for 45 min stained with ethidium bro-mide and photographed on a UV Transilluminator.
3.4. Statistical AnalysesSPSS version 13.5 was employed to analyze the data, and a P < 0.05 was considered statistically significant.
4. ResultsFifty patients including 27 males and 23 females, aged between eight and 77 years (mean, 43 years) were en-rolled in the study. Thirty-three patients lived in a rural habitat and 44 patients referred exposure to animals or 
their products. Most patients had fever and night sweat-ing (91%), sever weakness (82%), arthralgia (79%) and back-ache (67%). All patients gave a history of animal contact or ingestion of unpasteurized dairy products.A total of 50 blood culture bottles were processed dur-ing the evaluation period, out of which, seven (14%) were positive by BACTEC system (Table 1), with a mean detec-tion time of six days. No growth was detected by BACTEC system in 43 (86%) cases. All blood culture bottles were subcultured on sheep blood agar and chocolate agar plates. The media were incubated at 35°C in a 5% CO2-en-riched atmosphere and examined daily for four days. Sus-pected colonies were identified by standard tests. All iso-lates were identified as B.melitensis by agglutination test using species specific antisera. Seventeen (34%) out of 50 brucellosis patients were PCR positive with both whole-blood and serum samples collected before treatment, 11 (22%) were positive with whole-blood and 17 (34%) with se-rum samples. Out of 43 blood culture negative samples, 10 (23.3 %) were positive with the serum PCR versus 4 (9.3 %) with whole-blood PCR.  Table 1  shows the diagnostic re-sults of serum and whole blood PCR compared with rapid culture method for the 50 cases of brucellosis.
Table 1. Comparison of the Results of PCR-Based Assay with Microbiological Methods for the Diagnosis of Brucellosis
Result of Routine 
Procedure
Positive Serum PCR Negative Serum PCR Positive Whole blood 
PCR
Negative Whole-Blood PCR
Positive blood culture 7 0 7 0
Negative blood cul-
ture
10 33 4 39
Total 17 33 11 39
5. DiscussionAs the clinical presentation of human brucellosis is quite nonspecific, it is needed to resort to isolation of the microorganism, by demonstrating high levels of specific antibodies or seroconversion, to make a precise diagno-sis. However, all these methods have serious restrictions. In the current study, the authors evaluated the diagnosis of brucellosis before antibiotic treatment by culture, STA, and PCR methods. Although culture is the ‘Gold stan-dard’ in microbial diagnosis, culture may sometimes be abolished by factors innate to the microbe itself in spite of strict laboratory measures undertaken. This view was supported by the use of PCR in the current study to iden-tify ten culture negative patients with clinical symptoms of brucellosis. The antibody profiles for these patients showed high agglutination titers of Brucella-specific an-tibodies in most sera.In the current study, the sensitivity of BACTEC to iso-late Brucella was low (14%) and the average incubation time for positive culture was relatively prolonged (six days). In other studies, the sensitivity of blood culture by 
BACTEC varied between 30 to 90%, and incubation time between three to seven days (10, 14-16). The reason for these discrepancies may be related to the discrepancies of disease stage in the population under study, in various reports, because the least rates of positive blood culture are seen in chronic brucellosis and the highest in acute febrile brucellosis. Likewise, the sensitivity of PCR may be affected by the stage and severity of the disease.  This may explain the lower sensitivity of PCR in the current study compared to those of the previous studies. Moreover, the method of PCR may also be important. In a study con-ducted by Al-Ajlan et al. (17), the comparison of different methods of PCR ti diagnose brucellosis revealed that RT-PCR was more sensitive than conventional PCR with 77.5% sensitivity in whole blood and 60% in serum.Hedayati et al. (18) developed an improved PCR assay for the rapid and specific laboratory diagnosis of acute brucellosis from serum specimens of 30 Iranian patients. Alimoghadam et al. (19) determined optmization of PCR conditions  to detect Brucella in 16 serum samples from Iranian patients with brucellosis. An important point in the current study was the higher sensitivity of PCR of se-
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rum compared to those of whole blood. Various results were observed in previous studies. Keid et al. (20) com-pared the PCR of whole blood and serum  to diagnose  ca-nine brucellosis in Brazil. The higher sensitivity of PCR of whole blood (97%) than that of serum (25.7%) was report-ed. On the other hand,  Zerva et al. (16) compared serum and whole blood samples  to diagnose human brucellosis by PCR. They concluded that serum is the preferred clini-cal specimen for the molecular diagnosis of brucellosis.Serum may have some preferences over whole-blood sample in PCR method. Several inhibitor substances such as anticoagulants, hemoglobin, and human DNA are present in whole blood but not in serum. Red blood cell lysis, washings by centrifugation, and measurement and adjustment of isolated DNA concentrations are not re-quired (16). Overall, the use of serum is simple and short-ens the time, and sensitivity may be increased. In conclu-sion, the current study results indicate that serum is the preferred clinical specimen to detect Brucella by PCR. The usefulness of this method to diagnose various stages of brucellosis including the currently problematic chronic and relapsing diseases needs further investigation.
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